| Product Code: ETC13027981 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, New Zealand saw a diverse range of animal drug compounding imports from top countries including Australia, Metropolitan France, Spain, Ireland, and Germany. Despite the low concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 stood at a steady 3.11%. However, a notable decline in the growth rate from 2023 to 2024 at -16.18% suggests a potential shift in market dynamics or regulatory changes impacting the industry. Monitoring these trends will be crucial for stakeholders in the animal drug compounding sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Animal Drug Compounding Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Animal Drug Compounding Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Animal Drug Compounding Market - Industry Life Cycle |
3.4 New Zealand Animal Drug Compounding Market - Porter's Five Forces |
3.5 New Zealand Animal Drug Compounding Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 New Zealand Animal Drug Compounding Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 New Zealand Animal Drug Compounding Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 New Zealand Animal Drug Compounding Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 New Zealand Animal Drug Compounding Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for customized medications for animals |
4.2.2 Growing pet ownership and focus on animal health |
4.2.3 Rising prevalence of chronic diseases in animals |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements for drug compounding |
4.3.2 Limited awareness and understanding of animal drug compounding |
4.3.3 Potential safety concerns associated with compounded medications |
5 New Zealand Animal Drug Compounding Market Trends |
6 New Zealand Animal Drug Compounding Market, By Types |
6.1 New Zealand Animal Drug Compounding Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Animal Drug Compounding Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 New Zealand Animal Drug Compounding Market Revenues & Volume, By Oral Compounds, 2021 - 2031F |
6.1.4 New Zealand Animal Drug Compounding Market Revenues & Volume, By Topical Compounds, 2021 - 2031F |
6.1.5 New Zealand Animal Drug Compounding Market Revenues & Volume, By Injectable Compounds, 2021 - 2031F |
6.1.6 New Zealand Animal Drug Compounding Market Revenues & Volume, By Ophthalmic Compounds, 2021 - 2031F |
6.1.7 New Zealand Animal Drug Compounding Market Revenues & Volume, By Otic Compounds, 2021 - 2031F |
6.2 New Zealand Animal Drug Compounding Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Animal Drug Compounding Market Revenues & Volume, By Companion Animals, 2021 - 2031F |
6.2.3 New Zealand Animal Drug Compounding Market Revenues & Volume, By Livestock, 2021 - 2031F |
6.2.4 New Zealand Animal Drug Compounding Market Revenues & Volume, By Equine, 2021 - 2031F |
6.2.5 New Zealand Animal Drug Compounding Market Revenues & Volume, By Exotic Pets, 2021 - 2031F |
6.2.6 New Zealand Animal Drug Compounding Market Revenues & Volume, By Small Animals, 2021 - 2031F |
6.3 New Zealand Animal Drug Compounding Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Animal Drug Compounding Market Revenues & Volume, By Veterinary Care, 2021 - 2031F |
6.3.3 New Zealand Animal Drug Compounding Market Revenues & Volume, By Livestock Farming, 2021 - 2031F |
6.3.4 New Zealand Animal Drug Compounding Market Revenues & Volume, By Equine Care, 2021 - 2031F |
6.3.5 New Zealand Animal Drug Compounding Market Revenues & Volume, By Exotic Pet Care, 2021 - 2031F |
6.3.6 New Zealand Animal Drug Compounding Market Revenues & Volume, By Small Animal Care, 2021 - 2031F |
6.4 New Zealand Animal Drug Compounding Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Animal Drug Compounding Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.4.3 New Zealand Animal Drug Compounding Market Revenues & Volume, By Online Sales, 2021 - 2031F |
7 New Zealand Animal Drug Compounding Market Import-Export Trade Statistics |
7.1 New Zealand Animal Drug Compounding Market Export to Major Countries |
7.2 New Zealand Animal Drug Compounding Market Imports from Major Countries |
8 New Zealand Animal Drug Compounding Market Key Performance Indicators |
8.1 Number of veterinary clinics offering compounded medications |
8.2 Percentage of pet owners opting for customized medications for their animals |
8.3 Growth in the number of chronic disease cases in animals treated with compounded drugs |
9 New Zealand Animal Drug Compounding Market - Opportunity Assessment |
9.1 New Zealand Animal Drug Compounding Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 New Zealand Animal Drug Compounding Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 New Zealand Animal Drug Compounding Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 New Zealand Animal Drug Compounding Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 New Zealand Animal Drug Compounding Market - Competitive Landscape |
10.1 New Zealand Animal Drug Compounding Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Animal Drug Compounding Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |